Skip to content
Screener

Savara SVRA Common Stock

Common Stock at other companies

Innoviva, Inc. logo
Innoviva, Inc.INVA
$727K+15.4%
XER
Xeris Biopharma Holdings, Inc.XERS
$18K+12.5%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$6K0.0%
Upstream Bio, Inc. logo
Upstream Bio, Inc.UPB
$54K0.0%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$3K+50.0%
PVL
Palvella TherapeuticsPVLA
$14K+27.3%

Other financials

Income statement

See full
Revenue-
Operating income-$41.0M-30.3%
Net income-$40.2M-32.3%
EPS (diluted)-$0.16-14.3%

Balance sheet

See full
Cash & equivalents$41.8M+140%
Total debt$31.2M+5.2%
Total equity$143.7M+19.2%
Total assets$192.1M+17.3%

Cash flow

See full
Operating cash flow-$29.7M-13.3%
CapEx$222.0K+1,380%
Free cash flow-$30.0M-14.1%

Valuation

See full
Market cap$1.17B+152%
Enterprise value$1.16B+143%

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-105.5%+7.0pp
Debt / equity0.2×0.0×
Current ratio10.1×-0.9×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The source filing: Savara’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-344585
Line itemJune 30, 2026December 31, 2025
Total liabilities48,47850,303
Commitments and contingencies (Note 9)
Stockholders’ equity:
Common stock, $0.001 par value, 600,000,000 authorized as of June 30, 2026 and 300,000,000 authorized as of December 31, 2025; 205,399,365 and 204,567,283 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively204204
Additional paid-in capital829,589811,103
Accumulated other comprehensive loss(534)(87)
Accumulated deficit(685,599)(608,087)
Total stockholders' equity143,660203,133

Cover / Front Matter

FAQ

What is Savara's common stock?
Savara (SVRA) reported common stock of $204K in Q2 2026.
How has Savara's common stock changed year-over-year?
Savara's common stock increased by 17.9% year-over-year, from $173K to $204K.
What is the long-term trend for Savara's common stock?
Over 5 years (2020 to 2025), Savara's common stock has grown at a 30.0% compound annual growth rate (CAGR), from $55K to $204K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Savara's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude